GDRX
GoodRx Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$3.48
−1.42%Year over year
Reported trailing growth
- Revenue
- -1.8%
- EBITDA
- -16.6%
- EBIT
- -10.3%
- EPS
- -55.5%
- Free cash flow
- +9.3%
- Operating cash flow
- +5.8%
Forward estimates
Based on analyst estimates
- Revenue
- +3.4%
- EBITDA
- +104.0%
- EPS
- +542.3%
Three-year CAGR
- Revenue
- +1.3%
- EBITDA
- +41.4%
- EBIT
- +269.2%
- Net income
- +85.7%
- EPS
- +100.9%
- Free cash flow
- +21.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026